Helicobacter Pylori Infections companies are Servatus Biopharmaceuticals, Cinclus Pharma Holding AB, Crestone, EpiVax, Iguana Biotechnology, ImevaX GmbH, ImmunoBiology, Luoxin Pharmaceuticals, ...
The predominant H. pylori strain circulating among geographic locations differs with regard to the genomic structure. This study determined whether structural subtypes of the cagA 3′ repeat region ...
DUBLIN--(BUSINESS WIRE)--The "Helicobacter Pylori Infections - Market Insight, Epidemiology And Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering. This report delivers ...
A research team led by Professor Leung Wai-keung from Department of Medicine, School of Clinical Medicine, LKS Faculty of Medicine, the University of Hong Kong (HKUMed) and the Baylor College of ...
DelveInsight's Helicobacter pylori Infection Market report offers an in-depth understanding of the epidemiology and market trends in the 7MM. LAS VEGAS, NV, UNITED STATES, January 17, 2025 ...
The Helicobacter pylori Infection market size was valued approximately USD 3,489 million in 2022, forecasted to grow during the study period (2020-2034). NEVADA, LA, UNITED STATES, June 27, 2024 ...
Autoimmune gastritis is a chronic progressive inflammatory condition that results in the replacement of the parietal cell mass by atrophic and metaplastic mucosa. A complex interaction of ...
There is currently no evidence to suggest that Helicobacter pylori (H. pylori) can cause irritable bowel syndrome (IBS). However, as H. pylori has similar symptoms, some people may confuse the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback